ICU Medical CFO Sells Shares Under Pre-Set Trading Plan
On August 31, 2026, ICU Medical's Chief Financial Officer Brian Bonnell sold 9,307 shares of the company for a total value of $1.6 million through multiple transactions under a Rule 10b5-1 trading plan. The sale occurred at prices ranging from $170.57 to $174.08 per share and was part of an established schedule set in June 2026, indicating it wasn't a spontaneous decision. Following the transaction, Bonnell retained ownership of 62,443 shares valued at approximately $10.8 million as of August 31 market close ($172.95 per share), representing about 0.2% of ICU Medical's total company value. The stock had delivered a 35% return over the one-period ending on that date, suggesting strong performance in recent months. ICU Medical operates globally with proprietary technology platforms and serves hospitals and healthcare providers through infusion therapy and critical care solutions. With $2.2 billion in trailing twelve-month revenue and a market cap of $3.8 billion, it remains positioned as a key player in the medical device sector.
Tickers: $ICUI